On March 21, 2024, Fate Therapeutics, Inc closed the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.8 USD | -1.81% | -20.67% | +1.60% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.60% | 433M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- FATE Stock
- News Fate Therapeutics, Inc.
- Fate Therapeutics, Inc. announced that it has received $19.996366 million in funding from Redmile Group, LLC